BridgeBio Pharma, Inc. (BBIO)  Description, Stock price, News & Info.

#ThinkSabio Latest News

BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia